1. Home
  2. SPPL vs CARA Comparison

SPPL vs CARA Comparison

Compare SPPL & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPPL
  • CARA
  • Stock Information
  • Founded
  • SPPL 2016
  • CARA 2004
  • Country
  • SPPL Singapore
  • CARA United States
  • Employees
  • SPPL N/A
  • CARA N/A
  • Industry
  • SPPL
  • CARA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPPL
  • CARA Health Care
  • Exchange
  • SPPL Nasdaq
  • CARA Nasdaq
  • Market Cap
  • SPPL 14.8M
  • CARA 16.7M
  • IPO Year
  • SPPL 2023
  • CARA 2014
  • Fundamental
  • Price
  • SPPL $0.80
  • CARA $0.42
  • Analyst Decision
  • SPPL
  • CARA Hold
  • Analyst Count
  • SPPL 0
  • CARA 3
  • Target Price
  • SPPL N/A
  • CARA $1.00
  • AVG Volume (30 Days)
  • SPPL 217.8K
  • CARA 3.2M
  • Earning Date
  • SPPL 12-31-2024
  • CARA 11-14-2024
  • Dividend Yield
  • SPPL N/A
  • CARA N/A
  • EPS Growth
  • SPPL N/A
  • CARA N/A
  • EPS
  • SPPL N/A
  • CARA N/A
  • Revenue
  • SPPL $3,550,862.00
  • CARA $8,686,000.00
  • Revenue This Year
  • SPPL N/A
  • CARA N/A
  • Revenue Next Year
  • SPPL N/A
  • CARA N/A
  • P/E Ratio
  • SPPL N/A
  • CARA N/A
  • Revenue Growth
  • SPPL N/A
  • CARA N/A
  • 52 Week Low
  • SPPL $0.25
  • CARA $0.23
  • 52 Week High
  • SPPL $6.72
  • CARA $1.15
  • Technical
  • Relative Strength Index (RSI)
  • SPPL 42.72
  • CARA 75.98
  • Support Level
  • SPPL $0.81
  • CARA $0.23
  • Resistance Level
  • SPPL $0.94
  • CARA $0.52
  • Average True Range (ATR)
  • SPPL 0.07
  • CARA 0.05
  • MACD
  • SPPL -0.04
  • CARA 0.01
  • Stochastic Oscillator
  • SPPL 12.15
  • CARA 66.87

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Share on Social Networks: